Gurjit Singh Kaeley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gurjit Singh Kaeley has a total of 173 co-authors. Here are the top co-authors by number of shared publications:
- Lihi Eder
Women's College Hospital, University of Toronto Toronto Ontario Canada
12 shared publications - Sibel Zehra Aydin
Division of Rheumatology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
11 shared publications - Veena K. Ranganath
Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
8 shared publications - David Elashoff
Department of Medicine Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA
5 shared publications - Jenny Brook
Department of Medicine Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA
5 shared publications Catherine Bakewell
Intermountain Healthcare Medical Group , Salt Lake City, UT, USA
4 shared publications
Latest Publications
- 15 September 2026
- Published by The Journal of Rheumatology in The Journal of Rheumatology
Validation of Handheld Ultrasound Devices for Point-of-Care Use in Rheumatology: Focus on Synovitis, Doppler Activity, Erosions, and Tendon Lesions
Objective: Ultrasonography (US) is essential in rheumatology, but conventional systems are costly and not easily portable. Handheld US offers affordable, portable options, yet their diagnostic validity in psoriatic arthritis (PsA) is unclear. This study assessed the concurrent validity of handheld US devices in PsA by evaluating agreement with a gold-standard scanner in detecting elementary lesions. Methods: Patients with PsA meeting Classification Criteria for Psoriatic Arthritis (CASPAR) and presenting ≥ 1 tender and swollen joint underwent same-day US with handheld (Clarius L20/L15) and gold-standard (GE Logiq E9/E10) systems using a standardized protocol. A blinded assessor scored anonymized images for synovitis, Doppler signals, erosions, and tendon/tenosynovitis based on Outcome Measures in Rheumatology (OMERACT) definitions. Interdevice agreement was analyzed using Cohen κ (lesion detection), weighted κ (lesion scoring), and intraclass correlation coefficient (ICC) per patient. Results: Thirty patients were included. Between devices, agreement for detecting synovitis was moderate (κ 0.46-0.49). For Doppler activity, moderate agreement was found with Clarius L15 (κ 0.42) and fair agreement with Clarius L20 (κ 0.37). Erosions showed moderate-to-substantial agreement (L15: κ 0.57, L20: κ 0.62), whereas tendon inflammation had no-to-fair agreement (L15: κ 0.16, L20: κ −0.05). When compared with the gold-standard device, per-patient agreement showed poor (Global OMERACT–European Alliance of Associations for Rheumatology [EULAR] Synovitis Score [GLOESS]) and moderate agreement (Doppler) for L15, and good (GLOESS) and moderate (Doppler) agreement for L20. Conclusion: Handheld US devices demonstrated moderate agreement with high-end scanners in identifying and grading synovitis and erosions, suggesting promising potential for clinical application. However, sensitivity for Doppler activity and tendon lesions remains lower, emphasizing the need for continued optimization and validation.
- 15 September 2026
- Published by The Journal of Rheumatology in The Journal of Rheumatology
Validation of Handheld Ultrasound Devices for Point-of-Care Use in Rheumatology: Focus on Synovitis, Doppler Activity, Erosions, and Tendon Lesions
Objective: Ultrasonography (US) is essential in rheumatology, but conventional systems are costly and not easily portable. Handheld US offers affordable, portable options, yet their diagnostic validity in psoriatic arthritis (PsA) is unclear. This study assessed the concurrent validity of handheld US devices in PsA by evaluating agreement with a gold-standard scanner in detecting elementary lesions. Methods: Patients with PsA meeting Classification Criteria for Psoriatic Arthritis (CASPAR) and presenting ≥ 1 tender and swollen joint underwent same-day US with handheld (Clarius L20/L15) and gold-standard (GE Logiq E9/E10) systems using a standardized protocol. A blinded assessor scored anonymized images for synovitis, Doppler signals, erosions, and tendon/tenosynovitis based on Outcome Measures in Rheumatology (OMERACT) definitions. Interdevice agreement was analyzed using Cohen κ (lesion detection), weighted κ (lesion scoring), and intraclass correlation coefficient (ICC) per patient. Results: Thirty patients were included. Between devices, agreement for detecting synovitis was moderate (κ 0.46-0.49). For Doppler activity, moderate agreement was found with Clarius L15 (κ 0.42) and fair agreement with Clarius L20 (κ 0.37). Erosions showed moderate-to-substantial agreement (L15: κ 0.57, L20: κ 0.62), whereas tendon inflammation had no-to-fair agreement (L15: κ 0.16, L20: κ −0.05). When compared with the gold-standard device, per-patient agreement showed poor (Global OMERACT–European Alliance of Associations for Rheumatology [EULAR] Synovitis Score [GLOESS]) and moderate agreement (Doppler) for L15, and good (GLOESS) and moderate (Doppler) agreement for L20. Conclusion: Handheld US devices demonstrated moderate agreement with high-end scanners in identifying and grading synovitis and erosions, suggesting promising potential for clinical application. However, sensitivity for Doppler activity and tendon lesions remains lower, emphasizing the need for continued optimization and validation.
- 20 March 2026
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 85 (6) , 1-8
How ultrasound changed the practice of rheumatology: echoes of a 30-year collaboration
Ultrasound in medicine has a history arbitrarily going back to the days when a modified custom-built metal flaw detector was used in post-War Glasgow to diagnose abdominal masses. Spanning a period of 30 years, the article describes the coming of age of ultrasound within the field of rheumatology. This historical paper highlights collaborative research focusing on validation and standardization of the imaging modality. In addition, the work of several persons who have played a key role in the development of ultrasound in the field of rheumatology is emphasized. In real time and at the point of care, ultrasound can demonstrate where inflammation is present, thereby giving doctors and patients a better idea of why and where pain and stiffness originate. In retrospect, we may conclude that ultrasound has profoundly changed the practice of clinical rheumatology.
- 20 March 2026
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 85 (6) , 1-8
How ultrasound changed the practice of rheumatology: echoes of a 30-year collaboration
Ultrasound in medicine has a history arbitrarily going back to the days when a modified custom-built metal flaw detector was used in post-War Glasgow to diagnose abdominal masses. Spanning a period of 30 years, the article describes the coming of age of ultrasound within the field of rheumatology. This historical paper highlights collaborative research focusing on validation and standardization of the imaging modality. In addition, the work of several persons who have played a key role in the development of ultrasound in the field of rheumatology is emphasized. In real time and at the point of care, ultrasound can demonstrate where inflammation is present, thereby giving doctors and patients a better idea of why and where pain and stiffness originate. In retrospect, we may conclude that ultrasound has profoundly changed the practice of clinical rheumatology.
- 19 March 2026
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 40 (3) , 102128
The promise of imaging in psoriatic arthritis
- 19 March 2026
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 40 (3) , 102128
The promise of imaging in psoriatic arthritis
- Open Access
- 19 March 2026
- Published by Springer Nature in Rheumatology and Therapy
- Vol. 13 (3) , 467-490
A Narrative Review of Secukinumab in Spondyloarthritis and Psoriatic Arthritis: Treating the Whole Patient
Spondyloarthritis (SpA), including axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA), comprises a diverse but interrelated family of inflammatory diseases characterized by inflammation of the joints and spine. Signs and symptoms of SpA vary widely, as patients experience a diverse spectrum of musculoskeletal and extra-musculoskeletal disease manifestations. Interleukin (IL)-17 is an inflammatory cytokine common to the pathogenesis of SpA disease development and progression. The IL-17A inhibitor secukinumab has been well established in clinical trials and real-world practice as an effective therapeutic tool to efficiently manage SpA indications axSpA and PsA in adults, as well as juvenile PsA (jPsA) and enthesitis-related arthritis (ERA), which are two subtypes of juvenile idiopathic arthritis. This review highlights the comprehensive response to IL-17 inhibition with secukinumab across SpA indications of PsA, axSpA, and ERA/jPsA and within each indication according to established disease domains. We provide context through expert commentary on the effect of inhibiting IL-17 with secukinumab on the full spectrum of SpA disease manifestations, as well as areas in need of further investigation.
- 19 March 2026
- Published by Springer Nature in Rheumatology and Therapy
- Vol. 13 (3) , 467-490
Open AccessA Narrative Review of Secukinumab in Spondyloarthritis and Psoriatic Arthritis: Treating the Whole Patient
Spondyloarthritis (SpA), including axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA), comprises a diverse but interrelated family of inflammatory diseases characterized by inflammation of the joints and spine. Signs and symptoms of SpA vary widely, as patients experience a diverse spectrum of musculoskeletal and extra-musculoskeletal disease manifestations. Interleukin (IL)-17 is an inflammatory cytokine common to the pathogenesis of SpA disease development and progression. The IL-17A inhibitor secukinumab has been well established in clinical trials and real-world practice as an effective therapeutic tool to efficiently manage SpA indications axSpA and PsA in adults, as well as juvenile PsA (jPsA) and enthesitis-related arthritis (ERA), which are two subtypes of juvenile idiopathic arthritis. This review highlights the comprehensive response to IL-17 inhibition with secukinumab across SpA indications of PsA, axSpA, and ERA/jPsA and within each indication according to established disease domains. We provide context through expert commentary on the effect of inhibiting IL-17 with secukinumab on the full spectrum of SpA disease manifestations, as well as areas in need of further investigation.
- 7 August 2025
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 39 (3) , 102088
Imaging rheumatology: Emerging tools and expanding applications
- 7 August 2025
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 39 (3) , 102088
Imaging rheumatology: Emerging tools and expanding applications
- 5 August 2025
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 52 (Suppl 3) , 16-18
Toward Increasing Precision in the Early Diagnosis of Psoriatic Arthritis
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) ultrasound (US) group continued its focus on developing an early diagnostic tool for psoriatic arthritis (PsA). During the annual US workshop at the GRAPPA 2024 annual meeting in Seattle, Washington, participants reviewed preliminary analyses from the Diagnostic Ultrasound Enthesitis Tool (DUET) study and discussed the initial results of a DUET substudy aimed at defining enthesitis at the single enthesis level. Participants also previewed the ongoing systematic review of articular and periarticular manifestations of PsA, with particular attention to smaller joints. A summary of the 2024 US workshop is given herein.
- 5 August 2025
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 52 (Suppl 3) , 16-18
Toward Increasing Precision in the Early Diagnosis of Psoriatic Arthritis
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) ultrasound (US) group continued its focus on developing an early diagnostic tool for psoriatic arthritis (PsA). During the annual US workshop at the GRAPPA 2024 annual meeting in Seattle, Washington, participants reviewed preliminary analyses from the Diagnostic Ultrasound Enthesitis Tool (DUET) study and discussed the initial results of a DUET substudy aimed at defining enthesitis at the single enthesis level. Participants also previewed the ongoing systematic review of articular and periarticular manifestations of PsA, with particular attention to smaller joints. A summary of the 2024 US workshop is given herein.
- 13 May 2025
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 39 (3) , 102072
Clinical utility of ultrasound and MRI in rheumatoid arthritis: An expert review
- 13 May 2025
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 39 (3) , 102072
Clinical utility of ultrasound and MRI in rheumatoid arthritis: An expert review
- Open Access
A rare case of aortitis and occlusive iliac thrombus due to Campylobacter fetus bacteremia
- Open Access
- 1 March 2025
- Published by Convin SA in Mediterranean Journal of Rheumatology
- Vol. 36 (1) , 140-143
Collateral Rescue, Arterial Burden: Untreated Takayasu Arteritis and its Long-Term Complications
- 1 March 2025
- Published by Convin SA in Mediterranean Journal of Rheumatology
- Vol. 36 (1) , 140-143
Open AccessCollateral Rescue, Arterial Burden: Untreated Takayasu Arteritis and its Long-Term Complications